First precision radiopharmaceutical therapy targeting DLL3 being advanced for the treatment of small cell lung cancer and large cell neuroendocrine carcinoma SOUTH SAN FRANCISCO, CA – Abdera Therapeutics Inc., a… Read More
ABRYSVO is the only RSV vaccine authorized for the prevention of RSV in infants via immunization of pregnant individuals and in adults age 60 years and older Availability of ABRYSVO… Read More
Approval is based on the two largest Phase III trials conducted in HS – SUNSHINE and SUNRISE – demonstrating the safety and efficacy of Cosentyx® in HS1 HS is a chronic,… Read More
TORONTO, ON – LifeLabs is thrilled to announce Lawrence Mahan, SVP of Business & Consumer Markets of LifeLabs, has been recognized by The Healthcare Technology Report in the category of… Read More
Jemperli received a reimburse with conditions recommendation from CDA-AMC marking an important milestone in advancing access to endometrial cancer treatments and securing public reimbursement Provincial and territorial governments will make the… Read More
